Cue Biopharma, Inc. - Common Stock —— 资产负债表 (NASDAQ:CUE) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 99.53 M83.4 M91.28 M61.53 M32.19 M42.21 M 负债总额 20.62 M17.91 M25.6 M24.45 M14.69 M15.78 M 权益总额 78.91 M65.49 M65.68 M37.09 M17.5 M26.43 M 负债及股东权益总额 99.53 M83.4 M91.28 M61.53 M32.19 M42.21 M 总债务 ——8.03 M4.2 M0— 净债务 ——8.03 M4.2 M0—

新闻

美国股市涨跌不一；截至收盘道琼斯工业平均指数下跌0.31%

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.31%

Morning News Wrap-Up, 5/1/26: Today’s Biggest Stock Market Stories! - TipRanks.com

What's Behind The Drop In Cue Biopharma Stock Today? - Cue Biopharma (NASDAQ:CUE)

Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases - Slideshow (NASDAQ:CUE) 2026-04-09

Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases Transcript

Cue BiopharmaQ1每股收益及营收超出预期

Cue Biopharma earnings beat by $0.10, revenue topped estimates

Cue Biopharma以每股0.28美元定价1000万美元公开发行

Cue Biopharma prices $10 million public offering at $0.28 per share

Cue Biopharma股价因公开发行公告暴跌

Cue Biopharma stock tumbles on public offering announcement